Taming the Morning Surge: A QbD-Engineered Multiparticulate Capsule for Sequential RAAS and β₁-Blockade in Circadian Hypertension
Abstract Purpose: Morning blood pressure surge increases cardiovascular risk due to circadian activation of the renin–angiotensin–aldosterone and sympathetic nervous systems. This study developed a Quality by Design (QbD)-based dual-release multiparticulate capsule providing immediate release of olmesartan medoxomil followed by pH-responsive delayed release of metoprolol succinate for chronotherapeutic management of circadian hypertension. Methods: Immediate and delayed-release pellets were prepared by extrusion-spheronization and optimized using Response Surface Methodology with a Box-Behnken Design. Critical formulation variables were optimized to maximize entrapment efficiency, production yield, and drug release. Optimized formulations were evaluated by FTIR, SEM, dissolution studies, release kinetics, and accelerated stability testing. Results: Optimized formulations showed excellent agreement with the quadratic models (R² = 0.9915–0.9988; p < 0.0001). Immediate-release olmesartan pellets provided rapid drug release, while Eudragit-coated metoprolol pellets minimized gastric release and achieved controlled intestinal release. The optimized capsule exhibited satisfactory physicochemical properties, high content uniformity, low friability, reproducible sequential drug release, and acceptable accelerated stability. Conclusion: The QbD-based multiparticulate system successfully combined immediate and delayed drug release in a single chronotherapeutic dosage form. The optimized formulation established a robust design space and demonstrated the potential of sequential multiparticulate delivery for improving management of the early morning hypertension surge.
Authors
- Suriya Prakaash Kannan
- Damodharan Narayanasamy (ORCID: https://orcid.org/0000-0003-4246-5351)
- Gokul Haribut (ORCID: https://orcid.org/0009-0002-0359-1937)
Institutions
- SRM Institute of Science and Technology (IN)
Publication Details
- Journal
- BioNanoScience
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1007/s12668-026-02965-z
- Primary Topic
- Advanced Drug Delivery Systems
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- SRM Institute of Science and Technology